Detalles de la búsqueda
1.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A;
121(4): e2308942121, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241441
2.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med;
384(11): 1003-1014, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730454
3.
Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials.
Stat Med;
38(23): 4503-4518, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31313349
4.
Less healthy breakfast cereals are promoted more frequently in large supermarket chains in Canada.
BMC Public Health;
17(1): 877, 2017 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29132346
5.
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Vaccine;
41(16): 2696-2706, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36935288
6.
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.
EBioMedicine;
93: 104590, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300931
7.
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.
Hum Vaccin Immunother;
18(1): 1908030, 2022 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34213402
8.
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
J Acquir Immune Defic Syndr;
89(4): 405-413, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34923559
9.
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
Nat Med;
28(9): 1924-1932, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35995954
10.
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.
EBioMedicine;
64: 103203, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493795
11.
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
J Acquir Immune Defic Syndr;
87(1): 671-679, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587505
12.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr;
87(1): 680-687, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587510
13.
Support for My Video is Support for Me: A YouTube Scoping Review of Videos Including Adolescents With Chronic Pain.
Clin J Pain;
35(5): 443-450, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30908334
14.
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment.
Viruses;
11(7)2019 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31277299
Resultados
1 -
14
de 14
1
Próxima >
>>